BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34678230)

  • 1. Selective activation of cannabinoid receptor-2 reduces white matter injury via PERK signaling in a rat model of traumatic brain injury.
    Li L; Luo Q; Shang B; Yang X; Zhang Y; Pan Q; Wu N; Tang W; Du D; Sun X; Jiang L
    Exp Neurol; 2022 Jan; 347():113899. PubMed ID: 34678230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis.
    Wang G; Shi Y; Jiang X; Leak RK; Hu X; Wu Y; Pu H; Li WW; Tang B; Wang Y; Gao Y; Zheng P; Bennett MV; Chen J
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2853-8. PubMed ID: 25691750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant ER Stress Induced Neuronal-IFNβ Elicits White Matter Injury Due to Microglial Activation and T-Cell Infiltration after TBI.
    Sen T; Saha P; Gupta R; Foley LM; Jiang T; Abakumova OS; Hitchens TK; Sen N
    J Neurosci; 2020 Jan; 40(2):424-446. PubMed ID: 31694961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD36 deletion prevents white matter injury by modulating microglia polarization through the Traf5-MAPK signal pathway.
    Hou X; Qu X; Chen W; Sang X; Ye Y; Wang C; Guo Y; Shi H; Yang C; Zhu K; Zhang Y; Xu H; Lv L; Zhang D; Hou L
    J Neuroinflammation; 2024 Jun; 21(1):148. PubMed ID: 38840180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model.
    Tao Y; Tang J; Chen Q; Guo J; Li L; Yang L; Feng H; Zhu G; Chen Z
    Brain Res; 2015 Mar; 1602():127-35. PubMed ID: 25625355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental GMH rat model.
    Tao Y; Li L; Jiang B; Feng Z; Yang L; Tang J; Chen Q; Zhang J; Tan Q; Feng H; Chen Z; Zhu G
    Brain Behav Immun; 2016 Nov; 58():118-129. PubMed ID: 27261088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cannabinoid receptor 2 agonist reduces blood-brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats.
    Li L; Yun D; Zhang Y; Tao Y; Tan Q; Qiao F; Luo B; Liu Y; Fan R; Xian J; Yu A
    Brain Res; 2018 Oct; 1697():113-123. PubMed ID: 29886251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cannabinoid type 2 receptor by JWH133 protects heart against ischemia/reperfusion-induced apoptosis.
    Li Q; Wang F; Zhang YM; Zhou JJ; Zhang Y
    Cell Physiol Biochem; 2013; 31(4-5):693-702. PubMed ID: 23711495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2 alleviates white matter injury after traumatic brain injury in mice might be mediated by regulation of DHCR24/LXR pathway in microglia.
    Li Z; Yu S; Li L; Zhou C; Wang L; Tang S; Gu N; Zhang Z; Huang Z; Chen H; Tang W; Wang Y; Yang X; Sun X; Yan J
    Clin Transl Med; 2024 Apr; 14(4):e1665. PubMed ID: 38649789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats.
    Fujii M; Sherchan P; Krafft PR; Rolland WB; Soejima Y; Zhang JH
    J Neurol Sci; 2014 Jul; 342(1-2):101-6. PubMed ID: 24819918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid type 2 receptor activation inhibits MPP
    Wang M; Liu M; Ma Z
    Mol Biol Rep; 2023 May; 50(5):4423-4433. PubMed ID: 36977807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Cannabinoid Type 2 Receptor in Microglia Reduces Neuroinflammation through Inhibiting Aerobic Glycolysis to Relieve Hypertension.
    Shan R; Zhang Y; Shi Y; Wang X; Wang X; Ma G; Li Q
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases.
    Hashiesh HM; Jha NK; Sharma C; Gupta PK; Jha SK; Patil CR; Goyal SN; Ojha SK
    Eur J Pharmacol; 2021 Oct; 909():174398. PubMed ID: 34332924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix Hemorrhage in the preterm via CX3CR1
    Tang J; Miao H; Jiang B; Chen Q; Tan L; Tao Y; Zhang J; Gao F; Feng H; Zhu G; Chen Z
    Neuropharmacology; 2017 Jun; 119():157-169. PubMed ID: 28153531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB
    Olianas MC; Dedoni S; Onali P
    Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.
    Molina-Holgado E; Vela JM; Arévalo-Martín A; Almazán G; Molina-Holgado F; Borrell J; Guaza C
    J Neurosci; 2002 Nov; 22(22):9742-53. PubMed ID: 12427829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL33 (Interleukin 33)/ST2 (Interleukin 1 Receptor-Like 1) Axis Drives Protective Microglial Responses and Promotes White Matter Integrity After Stroke.
    Xie D; Liu H; Xu F; Su W; Ye Q; Yu F; Austin TJ; Chen J; Hu X
    Stroke; 2021 Jun; 52(6):2150-2161. PubMed ID: 33902297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
    Gomez O; Sanchez-Rodriguez A; Le M; Sanchez-Caro C; Molina-Holgado F; Molina-Holgado E
    Br J Pharmacol; 2011 Aug; 163(7):1520-32. PubMed ID: 21480865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 4-mediated microglial inflammation exacerbates early white matter injury following experimental subarachnoid hemorrhage.
    Peng J; Xie Y; Pang J; Wu Y; Zhou J; Gu L; Guo K; Zhang L; Xie B; Yin S; Sun X; Chen L; Jiang Y
    J Neurochem; 2023 Jul; 166(2):280-293. PubMed ID: 37309616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting glial cannabinoid CB
    Espejo-Porras F; García-Toscano L; Rodríguez-Cueto C; Santos-García I; de Lago E; Fernandez-Ruiz J
    Br J Pharmacol; 2019 May; 176(10):1585-1600. PubMed ID: 29574689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.